NCT02751580

Telehealth in Improving Quality of Life in Patients During Post Radiation Therapy Visits

Completed NA Results posted Last updated 16 May 2025

What this trial tests

NA trial testing Telemedicine in Malignant Neoplasm in 37 participants. Completed in 8 August 2018.

Timeline

23 March 2016

Primary endpoint
8 August 2018

8 August 2018

Quick facts

Lead sponsor	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	37
Start date	23 March 2016
Primary completion	8 August 2018
Estimated completion	8 August 2018
Sites	1 location across United States

Drugs / interventions tested

• Telemedicine
• Questionnaire Administration

Conditions studied

• Malignant Neoplasm — all drugs for Malignant Neoplasm →

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Who can join

18 and older, any sex, with Malignant Neoplasm. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Feasibility of Conducting a Future Randomized Clinical Trial Comparing Telehealth and in Person Visits (i.e., Rate of Accrual) Primary · 24 months from first patient enrolled

The number of patients accrued each month will be analyzed via Poisson regression. The mean (monthly rate) will be estimated and tested against the null value of 4 patients per month using a 1-sided test with alpha 0.05. The proportion of enrolled subjects who are lost to follow-up will also be summarized.

Group	Value	95% CI
Health Services Research (Telehealth)	2.4	± 1.67

Patient Satisfaction With Telehealth Visits as Measured by the Patients Satisfaction With Cancer Care Score Secondary · 4 months from enrollment

Patients Satisfaction with Cancer Care score is an 18-item questionnaire with answers on a 5-point Likert scale. Lower scores are associated with higher satisfaction with caner care. The average will be computed and tested against the null value of 75 using a one-sample t-test with alpha 0.05.

Group	Value	95% CI
Health Services Research (Telehealth)	32
Health Services Research (Telehealth)	5

Number of Patients Satisfied With Physician Communication During Telehealth Visit Secondary · 4 months from enrollment

14 item communication assessment tool (CAT). The CAT addresses specifically patient satisfaction with key aspects of communication and interpersonal skills and items are scored on a 1-5 scale where 1 = poor and 5 = excellent and a higher score would indicate better communication skills

Group	Value	95% CI
Health Services Research (Telehealth)	37

Patient Distrust in the Healthcare System as Measured by the Health Care System Distrust Scale in Relation to Privacy of Medical Record (MR) Secondary · 4 months from enrollment

healthcare system distrust scale, designed to assess the belief that physicians would act in a patient's best interest to prevent a potentially negative important outcome (ref). This is a 10 item survey scored 1-5 where 1 = "strongly disagree" and 5 = "strongly agree" and higher scores generally indicate more distrust. Patient distrust was measured by asking if patients felt their Medical Record (MR) would be kept private or would be accessed without their permission.

Agree MR could be access without permission

Group	Value	95% CI
Health Services Research (Telehealth)	5

Unsure MR are kept private

Group	Value	95% CI
Health Services Research (Telehealth)	5

Physicians Ability to Evaluate a Patient During a Telehealth Visit as Measured by the Physician Questionnaire Secondary · 4 months from enrollment

9 question survey regarding the ease of use and efficacy of the telehealth platform. The items were yes or no questions (scored on 1 = yes and 0 = no) scale. Higher scores represent greater satisfaction with the platform.

Assess Symptoms

Group	Value	95% CI
Health Services Research (Telehealth)	11

Assess Treatment-Related Toxicity

Group	Value	95% CI
Health Services Research (Telehealth)	9

Physician Satisfaction With Post-treatment Telehealth Visit as Measured by the Modified Physician Satisfaction Scale Secondary · 4 months from enrollment

9-question survey regarding the ease of use and efficacy of the telehealth platform. The items were yes or no questions (scored on 1=yes and 0=no) scale. Higher scores represented greater satisfaction with the platform. Specifically looked at responses to the items regarding: accurate assessment of symptoms via telehealth, accurately assess treatment-related toxicity via telehealth, feeling sure they obtained all information needed to care for the patient, and if providers would use the telehealth system in the future.

Accurately Assess Symptoms

Group	Value	95% CI
Health Services Research (Telehealth)	11

Accurately Assess Treatment-related toxicity

Group	Value	95% CI
Health Services Research (Telehealth)	9

Obtained All Information Needed for Patient Care

Group	Value	95% CI
Health Services Research (Telehealth)	8

Agreed Would Use Telehealth in future

Group	Value	95% CI
Health Services Research (Telehealth)	10

Sponsor's own description

This pilot clinical trial studies how well telehealth works in patients during post radiation therapy visits. A telehealth virtual office visit can be performed from the patient's home or workplace, decreasing time spent traveling to visit site, time spent in waiting room, and cost to patient. Studying telehealth may improve quality of life in patients during post radiation therapy visit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.